FlowMD Feasibility Study
FLowMD
Feasibility of Using a Meditation App in Adults With Anxiety Disorder
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to learn if the FlowMD mobile app is feasible to be used to manage mild anxiety in adults. It will also learn if the app is effective at managing anxiety in adults. Participants will: Use the FlowMD app daily to complete a 1-5 minute guided breathwork session over the course of 4 weeks. Complete surveys at the beginning, midpoint, and end of the study to measure anxiety levels and usability of the app.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable anxiety
Started Oct 2025
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2025
CompletedFirst Submitted
Initial submission to the registry
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
June 29, 2026
June 1, 2026
1.2 years
June 1, 2026
June 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of the FlowMD mobile app
Outcome measured using the Feasibility Survey with a Max Score of 32 indicating strong feasibility
From enrollment to end of intervention at 4 weeks
Secondary Outcomes (3)
Generalized Anxiety Disorder-7 (GAD-7) Score
From Enrollment to the end of the intervention at 4 weeks
Hamilton Anxiety Rating Scale (HAM-A) Score
From Enrollment to the end of the intervention at 4 weeks
State-Trait Anxiety Inventory (STAI)
From Enrollment to the end of the intervention at 4 weeks
Study Arms (2)
Intervention
ACTIVE COMPARATORDaily guided breathwork using the FlowMD mobile app
Control
NO INTERVENTIONControl Group with no Intervention
Interventions
Eligibility Criteria
You may qualify if:
- Are 18-65 years old
- Have an anxiety disorder
- Have a smartphone
- Able to download the FlowMD app
- Willing to use the FlowMD meditation app for a daily 1-5 minute session for four consecutive weeks
- Able to provide feedback on the experience using the app
- Willing to participate in surveys to measure changes in anxiety levels
You may not qualify if:
- Are undergoing significant changes in psychiatric medication or therapy
- Have severe psychiatric conditions that might interfere with study participation (Schizophrenia, Bipolar Disorder, Major Depressive Disorder)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helfgott Research Institute
Portland, Oregon, 97201, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Zwickey, PhD
National University of Natural Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 1, 2026
First Posted
June 29, 2026
Study Start
October 15, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 29, 2026
Record last verified: 2026-06